Effettuare il login Iscriviti gratis

Apollo Endosurgery Inc Est. Q/Q di EPS

Cos'è Est. Q/Q di EPS di Apollo Endosurgery Inc?

Est. Q/Q di EPS di Apollo Endosurgery Inc è 0.00%

Qual è la definizione di Est. Q/Q di EPS?



Il tasso di crescita prospettico trimestrale dell'utile, anno su anno , è l'aumento stimato di EPS di una società per il prossimo trimestre rispetto alla performance di un trimestre precedente.

The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.

Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.

Est. Q/Q di EPS di aziende nel Health Care settore su NASDAQ rispetto a Apollo Endosurgery Inc

Cosa fa Apollo Endosurgery Inc?

Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.

Aziende con est. q/q di eps simili a Apollo Endosurgery Inc